Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

180 LIFE SCIENCES CORP.

(ATNF)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur 180 LIFE SCIENCES CORP.
06/12180 Life Sciences' Clinical Study For Dupuytren's Disease Meets Primary, Secondary Endp..
06/12180 LIFE SCIENCES : Life Sciences Provides Follow-Up Information on Oxford University and ..
06/12180 LIFE SCIENCES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
06/12180 Life Sciences Provides Follow-Up Information on Oxford University and the Company's..
01/12180 LIFE SCIENCES : Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynot..
01/12180 LIFE SCIENCES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
01/12180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at ..
22/11180 Life Sciences Expands Patent Portfolio With Treatments Related to Chronic Pain
22/11180 Life Sciences Corp. Expands Patent Portfolio
18/11180 LIFE SCIENCES : Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Ke..
18/11180 LIFE SCIENCES CORP. : Regulation FD Disclosure, Other Events, Financial Statements and..
18/11180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address..
15/11180 Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months ..
15/11Note 2 - going concern and management's plans
03/11180 Life Sciences Appoints Quan Vu as Chief Operating Officer
03/11180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
03/11180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
03/11180 Life Sciences Corp. Names Quan A. Vu as Chief Operating Officer/Chief Business Offi..
02/11180 LIFE SCIENCES CORP. : Change in Directors or Principal Officers, Financial Statements ..
26/10180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Deriv..
05/10180 LIFE SCIENCES : DEBT CONVERSION AGREEMENT (Form 8-K)
05/10180 LIFE SCIENCES CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of..
30/09180 LIFE SCIENCES : Receives Patent on Discovery to Reduce Post-Operative Cognitive Dysfun..
30/09180 LIFE SCIENCES CORP : . Continues To Expand Intellectual Property Portfolio
30/09180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio
20/09180 LIFE SCIENCES : SETTLEMENT AND MUTUAL RELEASE AGREEMENT (Form 8-K)
20/09180 LIFE SCIENCES CORP. : Entry into a Material Definitive Agreement, Change in Directors ..
20/09180 LIFE SCIENCES : Plans Supply Deal With Celltrion Healthcare For Anti-TNF Product Trial..
20/09Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a..
20/09Celltrion Healthcare and 180 Life Sciences Enter into Memorandum of Understanding for A..
20/09180 LIFE SCIENCES CORP.(NASDAQCM : ATNF) added to S&P Global BMI Index
30/08180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
30/08180 LIFE SCIENCES : Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockhol..
30/08180 LIFE SCIENCES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
27/08180 LIFE SCIENCES CORP. : Unregistered Sale of Equity Securities, Other Events (form 8-K)
24/08180 LIFE SCIENCES : Life Sciences Corp. Announces $15.0 Million Private Placement (Form 8-..
24/08180 LIFE SCIENCES CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of..
24/08180 LIFE SCIENCES CORP : . Announces Closing of $15.0 Million Private Placement
23/08180 Life Sciences Corp. announced that it has received $15 million in funding
19/08180 LIFE SCIENCES : Launches $15 Million Private Placement
19/08180 Life Sciences Corp. Announces $15.0 Million Private Placement
19/08180 Life Sciences to Raise $15 Million in Private Placement
19/08180 Life Sciences Corp. announced that it expects to receive $15 million in funding
16/08180 LIFE SCIENCES : Note 2 - going concern and management's plans
10/08180 LIFE SCIENCES : Amended and Restated by the Board of Directors of the Corporation on A..
10/08180 LIFE SCIENCES CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,..
06/08180 LIFE SCIENCES CORP. : Unregistered Sale of Equity Securities (form 8-K)
03/08180 LIFE SCIENCES : Settlement Agreement (Form 8-K)
02/08180 LIFE SCIENCES CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of..
02/08180 LIFE SCIENCES : Chairman of the 180 Life Sciences Clinical Advisory Board, Professor J..
29/07180 LIFE SCIENCES : to Participate in Fireside Chat at BTIG Virtual Biotechnology Conferen..
28/07180 LIFE SCIENCES : Announces Selection of Lead Synthetic CBD Analogue
28/07180 Life Sciences Corp. Announces Selection of Lead Synthetic CBD Analogue
20/07180 LIFE SCIENCES : Life Sciences Regains Nasdaq Compliance Under Listing Rule 5250(c)(1) ..
20/07180 LIFE SCIENCES CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
20/07180 LIFE SCIENCES : Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
19/07180 LIFE SCIENCES : Quarterly Report (SEC Filing - 10-Q)
19/07180 Life Sciences Corp. Reports Earnings Results for the First Quarter Ended March 31, ..
19/07180 LIFE SCIENCES : Note 2 - going concern and management's plans
12/07180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2)
12/07180 LIFE SCIENCES CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Ru..
09/07180 LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
09/07180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2..
07/07180 Life Sciences Expands Scientific Fibrosis Platform with Collagen VI as a Driver and..
28/06180 LIFE SCIENCES : Life Sciences Files Plan with Nasdaq Related to Delayed Quarterly Repo..
28/06180 LIFE SCIENCES CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Ru..
28/06180 Life Sciences Joins Russell Microcap® Index
28/06180 LIFE SCIENCES : Files Plan with Nasdaq Related to Delayed Quarterly Report on Form 10-..
10/06180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knue..
10/06180 LIFE SCIENCES : Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD a..
10/06180 LIFE SCIENCES CORP. : Change in Directors or Principal Officers, Unregistered Sale of ..
10/06180 Life Sciences Corp Announces Board Appointments
01/06180 LIFE SCIENCES CORP : . to Present at LD Micro Invitational XI
28/05180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeL..
27/05180 LIFE SCIENCES : Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA a..
1  2  3Suiv.
Prochain événement sur 180 LIFE SCIENCES CORP.